Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP408186.RAEFT4gSR8aMZlJresABtwM92slztBw48baHitbBzgyDA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP408186.RAEFT4gSR8aMZlJresABtwM92slztBw48baHitbBzgyDA130_assertion type Assertion NP408186.RAEFT4gSR8aMZlJresABtwM92slztBw48baHitbBzgyDA130_head.
- NP408186.RAEFT4gSR8aMZlJresABtwM92slztBw48baHitbBzgyDA130_assertion wasGeneratedBy ECO_0000203 NP408186.RAEFT4gSR8aMZlJresABtwM92slztBw48baHitbBzgyDA130_provenance.
- NP408186.RAEFT4gSR8aMZlJresABtwM92slztBw48baHitbBzgyDA130_assertion wasDerivedFrom befree-20140225 NP408186.RAEFT4gSR8aMZlJresABtwM92slztBw48baHitbBzgyDA130_provenance.
- NP408186.RAEFT4gSR8aMZlJresABtwM92slztBw48baHitbBzgyDA130_assertion SIO_000772 23358109 NP408186.RAEFT4gSR8aMZlJresABtwM92slztBw48baHitbBzgyDA130_provenance.
- NP408186.RAEFT4gSR8aMZlJresABtwM92slztBw48baHitbBzgyDA130_assertion evidence source_evidence_literature NP408186.RAEFT4gSR8aMZlJresABtwM92slztBw48baHitbBzgyDA130_provenance.
- NP408186.RAEFT4gSR8aMZlJresABtwM92slztBw48baHitbBzgyDA130_assertion description "[We hypothesized that a CRAd armed with osteoprotegerin (OPG), an inhibitor of osteoclastogenesis, would inhibit the progression of prostate cancer bone metastases by directly lysing tumor cells and by reducing osteoclast activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408186.RAEFT4gSR8aMZlJresABtwM92slztBw48baHitbBzgyDA130_provenance.